Vsn Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.50 Cr
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -58.54%
- Profit Growth -57.73%
- Ebitda -28.66%
- Net Worth 0.38%
- Total Assets 0.55%
About Vsn Pharmaceuticals
Vsn Pharmaceuticals Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 August 2013 and has a history of 11 years and five months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sadhan Roy, Suresh Agarwal, Nishant Chokhani, and One other member serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909WB2013PTC196529
-
Company No.
196529
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Aug 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Vsn Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sadhan Roy
|
Director | 19-Aug-2013 | Current |
|
Suresh Agarwal
|
Director | 16-Aug-2013 | Current |
|
Nishant Chokhani
|
Director | 16-Aug-2013 | Current |
|
Vineet Kothari
|
Director | 16-Aug-2013 | Current |
Financial Performance of Vsn Pharmaceuticals.
Vsn Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 58.54% decrease. The company also saw a substantial fall in profitability, with a 57.73% decrease in profit. The company's net worth moved up by a moderate rise of 0.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vsn Pharmaceuticals?
In 2020, Vsn Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Nu Sri Shyam Pharmaceuticals Private LimitedNishant Chokhani is a mutual person
-
Blue Print Pharmacy Private LimitedSuresh Agarwal is a mutual person
-
Shreepati Enclave Private LimitedSadhan Roy is a mutual person
-
Shreepati Apartments Pvt Ltd
Sadhan Roy is a mutual person
-
Centre Point Nursing Home Pvt. Ltd.
Sadhan Roy is a mutual person
-
Manshya Agro Private Limited
Suresh Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vsn Pharmaceuticals?
Unlock and access historical data on people associated with Vsn Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vsn Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vsn Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.